University of Missouri
Beta-myosin heavy chain myocytes are more resistant to power output changes during ischemia
Published in Health Business Week, March 3rd, 2006
According to a recent report from investigators in the United States, "During ischemia intracellular concentrations of Pi and H+ increase. Also, changes in myosin heavy chain (MHC) isoform toward beta-MHC have been reported after ischemia and infarction associated with coronary artery disease."
"The purpose of this study was to investigate the effects of myoplasmic changes of Pi and H+ on the loaded shortening velocity and power output of cardiac myocytes expressing either alpha- or beta-MHC,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-03-03)
More Articles from Health Business Week
- Advaxis, Inc.
Cancer vaccine developer completes $3M institutional financing - Alkermes, Inc.
Risperdal Consta maker reports second consecutive profitable quarter - Allied Healthcare Products, Inc.
Respiratory care product maker posts 72% increase in income - Aphton Corp.
Cancer immunotherapies developer receives delist determination from NASDAQ panel - Applied Imaging Corp.
Medical device maker reaffirms prior guidance for 2005 - Baxter International, Inc.
Infusion pump maker reports earnings of $0.60 per share - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
